ZA915593B - Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same - Google Patents

Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same

Info

Publication number
ZA915593B
ZA915593B ZA915593A ZA915593A ZA915593B ZA 915593 B ZA915593 B ZA 915593B ZA 915593 A ZA915593 A ZA 915593A ZA 915593 A ZA915593 A ZA 915593A ZA 915593 B ZA915593 B ZA 915593B
Authority
ZA
South Africa
Prior art keywords
virus
mounth
foot
disease
herpesvirus
Prior art date
Application number
ZA915593A
Other languages
English (en)
Inventor
Richard Dennis Dimarchi
Dennis Dimarchi Richard
Charles Gale
Gale Charles
Saul Kit
Kit Saul
Malon Kit
Kit Malon
Sheila Parks Little
Parks Little Sheila
Original Assignee
Novagene Inc
Baylor College Medicine
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagene Inc, Baylor College Medicine, Lilly Co Eli filed Critical Novagene Inc
Publication of ZA915593B publication Critical patent/ZA915593B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA915593A 1990-07-24 1991-07-17 Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same ZA915593B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55659390A 1990-07-24 1990-07-24

Publications (1)

Publication Number Publication Date
ZA915593B true ZA915593B (en) 1993-03-31

Family

ID=24221994

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915593A ZA915593B (en) 1990-07-24 1991-07-17 Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same

Country Status (5)

Country Link
EP (1) EP0471457A3 (xx)
AU (1) AU8126391A (xx)
CA (1) CA2047585A1 (xx)
IE (1) IE912591A1 (xx)
ZA (1) ZA915593B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0598759A4 (en) * 1991-07-18 1998-06-03 Syntro Corp RECOMBINANT VIRUS OF INFECTIOUS RHINE TRACHEITIS OF CATTLE.
WO1994024296A2 (en) * 1993-04-19 1994-10-27 University Of Saskatchewan Recombinant bovine herpesvirus type 1 vaccines
GB9720633D0 (en) * 1997-09-29 1997-11-26 Univ Bristol BHV-2 vector
GB9816775D0 (en) * 1998-07-31 1998-09-30 Efstathiou Stacey Herpesviral vectors for gene delivery
FR2810888B1 (fr) 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
MX388708B (es) 2014-09-23 2025-03-20 Boehringer Ingelheim Animal Health Usa Inc Vacunas recombinantes contra fmdv y sus usos.
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256092B1 (en) * 1986-01-27 1998-04-08 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
JPH02501186A (ja) * 1987-06-22 1990-04-26 メディコ ラブス アクチェンゲゼルシャフト 異種ウイルス性ペプチド粒子の免疫原
AU2888089A (en) * 1988-01-26 1989-07-27 Baylor College Of Medicine Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same
GB8920357D0 (en) * 1989-09-08 1989-10-25 Wellcome Found Peptides

Also Published As

Publication number Publication date
IE912591A1 (en) 1992-01-29
CA2047585A1 (en) 1992-01-25
EP0471457A3 (en) 1992-03-04
EP0471457A2 (en) 1992-02-19
AU8126391A (en) 1992-01-30

Similar Documents

Publication Publication Date Title
PL321966A1 (en) Vaccine against viral hepatitis of b type
CA2123612A1 (en) Hybrid protein between cs from plasmodium and h bsag
SE8102726L (sv) Nukleotidsekvens som kodar ytantigenet av hepatit b-virus,vektor innehallande nemda nukleotidsekvens,forfarande for erhallande derav samt erhallet antigen
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
AU9052091A (en) Vaccines based on hepatitis b surface antigen
HUT71791A (en) Combined vaccines comprising hepatitis b surface antigen and other antigens
CA2076744A1 (en) Viral Agent Associated with Mystery Swine Disease
CA2102918A1 (en) Genetic vaccine for immunodeficiency viruses
WO1995012677A3 (en) Immunodominant human t-cell epitopes of hepatitis c virus
OA09888A (en) HLA-restricted hepatitis B virus CTL epitopes.
NZ220612A (en) 11 residue influenza virus peptide and vaccines
ZA935723B (en) Hepatitis A virus vaccine.
EP0631506A4 (en) VACCINES COMPRISING SELECTIVELY DEGLYCOSYLATED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEINS.
GB2264949B (en) Measles virus recombinant poxvirus vaccine
ZA915593B (en) Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
PT85137A (en) T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen
EP0486106A3 (en) Marek's disease virus vaccine
OA09664A (en) Virus/herbicide-resistance genes, processes for the preparation thereof and the use thereof
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
ZA923070B (en) Multiple hepatitis b virus surface proteins which form particles
IL89118A0 (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
AU7909391A (en) Epitopes of the pre-s region of hepatitis b virus surface antigen
HU9203976D0 (en) Vaccine based on modified herpes virus
IL106592A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus